Trials / Completed
CompletedNCT05959213
Preoperative CA 19.9 Level Predicts Lymph Node Metastasis in Resectable Adenocarcinoma of the Head of the Pancreas.
Preoperative CA 19.9 Level Predicts Lymph Node Metastasis in Resectable Adenocarcinoma of the Head of the Pancreas: a Further Plea for Biological Resectability Criteria.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,034 (actual)
- Sponsor
- Fondazione Policlinico Universitario Campus Bio-Medico · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
In our multicenter retrospective study, preoperative CA 19.9 levels predicts the presence of lymph node metastasis at final histology in patients underwent pancreatoduodenectomy for pancreatic ductal adenocarcinoma .
Detailed description
A retrospective analysis have been conducted on more than 2.000 patients underwent pancreatoduodenectomy for pancreatic ductal adenocarcinoma radiologically resectable at the preoperative staging. Preoperatory levels of CA 19.9 were measured in order to identify a relation with nodal involvement at the pathological staging.
Conditions
Timeline
- Start date
- 2000-01-01
- Primary completion
- 2022-06-30
- Completion
- 2023-03-01
- First posted
- 2023-07-25
- Last updated
- 2023-07-25
Source: ClinicalTrials.gov record NCT05959213. Inclusion in this directory is not an endorsement.